Japanese Device Maker Nipro Estimates Further Growth For FY2009
This article was originally published in PharmAsia News
Executive Summary
Japanese medical device maker Nipro's 2008 sales grew by 2.2 percent to ¥175.9 billion. The operating income increased by 8 percent to ¥14.7 billion and net profit increased by 1.7 percent to ¥4.5 billion. In the domestic market, Nipro's dialysis products, injection and intravenous injection products steadily expanded market shares. Its pharmaceutical business also contributed to growth, especially in oral tablets and dialysis medicines. For fiscal year 2009, Nipro estimates further expansion in its pharma business, due largely to growth in the generic drug market and increasing diagnostic procedure combined payment methods. Estimated 2009 sales are ¥180 billion, with ¥6 billion in net product for a 33.5 percent increase. (Click here for more - Japanese language